Diabetes

As the prevalence of diabetes continues to increase globally, and the market for new therapies grows increasingly crowded, it's more important than ever to match the right drug to the right patient.

Doctor with Diabetes Patient
Featured Video

Global Impact of Diabetes
Erica Caveney discusses the global burden of diabetes. This is the player to use for single videos on Q.com This is the player to use for single videos on Q.com ...

Related Content

Did you know...

Quintiles has helped develop or commercialize 100% of all new NME/BLA Diabetes products approved 2004 through 2013.
63% of European payers and 79% of US payers fell that proving value in Diabetes treatments is easy.

Quintiles Blog

Fresh ideas and insights from our experts around the globe

Blog

Quintiles Expert

Vice President and Head of the Diabetes Center of Excellence

Recent thinking: New diabetes drugs: What's your hook?

Global Regulatory Strategy Lead

Recent thinking: Pediatric Type 2 Diabetes trials: Every patient is precious

Peer-Reviewed Publications
The patient care pathway for type 2 diabetes mellitus in Asian countries: implications on target physician group for diabetes clinical trials.
J Diabetes Metab 2014 5: 331
Read more
Pharmaceutical interventions for obesity: a public health perspective. 
Diabetes Obes Metab. 2011;13:490-497. 
Read more
Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. 
J Assoc Physicians of India. 2012;60:56-61. 
Read more